Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
9.87 x 1 10.20 x 3
Pre-market by (Cboe BZX)
9.75 +0.17 (+1.77%) 04/22/25 [NASDAQ]
9.87 x 1 10.20 x 3
Pre-market 9.75 unch (unch) 16:00 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
9.57
Day High
10.06
Open 9.75
Previous Close 9.58 9.58
Volume 1,391,700 1,391,700
Avg Vol 1,798,875 1,798,875
Stochastic %K 74.02% 74.02%
Weighted Alpha -36.60 -36.60
5-Day Change +0.03 (+0.31%) +0.03 (+0.31%)
52-Week Range 8.05 - 19.11 8.05 - 19.11
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,254,406
  • Shares Outstanding, K 128,657
  • Annual Sales, $ 660,570 K
  • Annual Income, $ -78,730 K
  • EBIT $ -92 M
  • EBITDA $ -17 M
  • 60-Month Beta 1.41
  • Price/Sales 1.87
  • Price/Cash Flow 21.77
  • Price/Book 1.36

Options Overview Details

View History
  • Implied Volatility 81.65% ( -4.95%)
  • Historical Volatility 80.72%
  • IV Percentile 95%
  • IV Rank 57.23%
  • IV High 121.33% on 04/10/25
  • IV Low 28.57% on 11/27/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 413
  • Volume Avg (30-Day) 281
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 16,171
  • Open Int (30-Day) 16,569

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.11
  • Number of Estimates 6
  • High Estimate -0.08
  • Low Estimate -0.11
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -37.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.05 +21.12%
on 04/09/25
Period Open: 9.86
10.37 -5.98%
on 03/24/25
-0.11 (-1.12%)
since 03/21/25
3-Month
8.05 +21.12%
on 04/09/25
Period Open: 14.50
15.32 -36.36%
on 01/28/25
-4.75 (-32.76%)
since 01/22/25
52-Week
8.05 +21.12%
on 04/09/25
Period Open: 13.42
19.11 -48.99%
on 01/08/25
-3.67 (-27.35%)
since 04/22/24

Most Recent Stories

More News
Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)

Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)

GH : 43.80 (+2.79%)
DGX : 172.84 (+6.78%)
NEO : 9.75 (+1.77%)
LH : 220.25 (+3.78%)
RDNT : 48.18 (+1.73%)
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

GH : 43.80 (+2.79%)
DGX : 172.84 (+6.78%)
NEO : 9.75 (+1.77%)
LH : 220.25 (+3.78%)
RDNT : 48.18 (+1.73%)
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack

GH : 43.80 (+2.79%)
DGX : 172.84 (+6.78%)
NEO : 9.75 (+1.77%)
LH : 220.25 (+3.78%)
RDNT : 48.18 (+1.73%)
Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses

Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses

GH : 43.80 (+2.79%)
DGX : 172.84 (+6.78%)
NEO : 9.75 (+1.77%)
LH : 220.25 (+3.78%)
RDNT : 48.18 (+1.73%)
3 Reasons to Sell NEO and 1 Stock to Buy Instead

3 Reasons to Sell NEO and 1 Stock to Buy Instead

CRWD : 368.45 (+1.59%)
NEO : 9.75 (+1.77%)
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)

GH : 43.80 (+2.79%)
DGX : 172.84 (+6.78%)
NEO : 9.75 (+1.77%)
LH : 220.25 (+3.78%)
RDNT : 48.18 (+1.73%)
3 Small-Cap Stocks in Hot Water

3 Small-Cap Stocks in Hot Water

AMN : 18.04 (+1.41%)
MATW : 19.48 (+0.52%)
NEO : 9.75 (+1.77%)
3 Healthcare Stocks Skating on Thin Ice

3 Healthcare Stocks Skating on Thin Ice

OMCL : 29.92 (+0.91%)
NEO : 9.75 (+1.77%)
SEM : 15.88 (+2.72%)
What To Expect From RadNet’s (RDNT) Q4 Earnings

What To Expect From RadNet’s (RDNT) Q4 Earnings

DGX : 172.84 (+6.78%)
NEO : 9.75 (+1.77%)
RDNT : 48.18 (+1.73%)
Why NeoGenomics (NEO) Shares Are Trading Lower Today

Why NeoGenomics (NEO) Shares Are Trading Lower Today

NEO : 9.75 (+1.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 10.51
2nd Resistance Point 10.28
1st Resistance Point 10.02
Last Price 9.75
1st Support Level 9.53
2nd Support Level 9.30
3rd Support Level 9.04

See More

52-Week High 19.11
Fibonacci 61.8% 14.89
Fibonacci 50% 13.58
Fibonacci 38.2% 12.28
Last Price 9.75
52-Week Low 8.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro